Verismo Therapeutics, a clinical-stage CAR T cell therapy company pioneering a novel multi-chain KIR-CAR platform technology, ...

CAR, was shown to be safe, with increasing efficacy corresponding to higher doses of the investigational treatment in nine ...

Deck Bio, a biotechnology company advancing multi-pMHC targeted T cell engagers for solid tumors, today presented new preclinical data for its lead program, DBXO-1, at the American Association for ...

The advent of single-cell omics technologies has revolutionized our understanding of the complex cellular landscape in cancer. Traditional bulk sequencing ...

Esophageal squamous cell carcinoma (ESCC) is the predominant histological subtype of esophageal cancer, accounting for ...

The immune system acts as a critical sentinel of organismal aging, integrating the sensing of physiological states with the ...

Cell number and viability matter from biological research to bioprocessing. So, scientists keep working on better ways to monitor these features of cell cultures. One promising approach comes from ...